Tango Therapeutics Statistics
NASDAQ: TNGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
22.52+0.69 (+3.16%)
Market open · Delayed 15 min · as of Oct 8, 3:35 PM ET
Tango Therapeutics by the numbers
Tango Therapeutics has a market capitalization of $3.80 billion based on 168.61M shares outstanding. With trailing EPS of $-0.85, Tango Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.7% below its 50-day average and 6.4% above its 200-day average.
Average daily trading volume is 2.61M shares, or about $58.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TNGX valuation vs. peer median
| Metric | TNGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.80B | $3.57B | +6% |
| Avg. volume | 2.61M | 1.89M | +38% |
Peer median across 8 companies: TLX, OGN, LEGN, VKTX, XENE, PBLS, ABCL, IDYA.
Valuation
- Market cap
- $3.80B
- Price / sales (latest FY)
- 60.87
- EPS (TTM)
- $-0.85
- Shares outstanding
- 168.61M
Price and trading
- Previous close
- 21.83
- Open
- 21.59
- Day range
- 20.99 – 22.68
- 52-week range
- 6.69 – 34.39
- 52-week change
- +199.45%
- Beta
- —
- Volume
- 3.28M
- Average volume
- 2.61M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 3.80B
- Forward Pe
- -13.36
- Eps
- -0.85
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 34.39
- Week52 Low
- 6.69
- Avg Volume
- 2.61M
- Shares Outstanding
- 168.61M
- Ma50
- 24.67
- Ma200
- 21.16
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -34.52%
- Pct From52w Low
- 236.62%